Skip to main content
    V

    vTv Therapeutics Inc (VTVT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $17.29
    -0.40 (-2.26%)

    Market Cap: $78.99M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    vTv Therapeutics Inc (VTVT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    vTv Therapeutics (VTVT) has a market cap of $78.99M and an enterprise value of $1.83M. Revenue grew 216458.82% over the last 12 months from the 12 months before. Its share count is up 54.22% from a year earlier.

    Total Valuation

    Enterprise value is 97.69% below the market cap, as cash exceeds debt.

    Market Cap$78.99M
    Enterprise Value$1.83M
    Latest price (Nov 17, 2026)$17.29

    Key Dates

    The next earnings report is expected on Mar 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 8, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.12% in the quarter ended Sep 30, 2026 and grew 50.90% a year over 2 years.

    Shares Outstanding12.42M
    Shares Change (YoY)+54.22%
    Shares Change (QoQ)+0.12%
    Share Count Growth (2Y CAGR)+50.90%

    Valuation Ratios

    Forward P/S2.6x
    P/B Ratio3.1x

    Price Statistics

    The stock is down 43.86% over 52 weeks and trades 36.94% below its 50-day average.

    Beta (1Y)1.41
    52-Week Change-43.86%
    1-Month Change-35.82%
    3-Month Change-47.44%
    6-Month Change-52.62%
    5-Year Change-56.00%
    10-Year Change-88.33%
    Total Return (1Y)-43.86%
    Total Return (3Y CAGR)+5.21%
    Total Return (5Y CAGR)-21.73%
    Return vs SPY (1Y)-54.14%
    Max Drawdown (1Y)-59.52%
    Max Drawdown (3Y)-59.52%
    Sharpe Ratio (1Y)-0.77
    Correlation with SPY (1Y)0.27
    50-Day Average$27.42
    200-Day Average$32.70
    52-Week Range$17.28 to $44.00
    RSI (14 Days)18.0
    Average Volume (20 Days)22.58K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 11.19x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio11.19x
    Quick Ratio11.19x
    Debt / Equity0.00x

    Returns and Efficiency

    ROA (5Y Average)-94.01%
    Asset Turnover0.41x

    Scores

    VTVT has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $36.81M over the last 12 months.

    Revenue$36.81M
    Revenue Growth (YoY)+216458.82%
    Gross Profit$36.84M
    Operating Income-$10.98M
    Pretax Income-$7.68M
    Net Income-$7.68M
    Reported EPS (TTM)-$0.92

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 88.65% of the $78.61M in total assets.

    Cash and Equivalents$77.16M
    Total Debt$0
    Net Cash$77.16M
    Net Cash Per Share$6.21
    Working Capital$71.58M
    Shareholder Equity$69.69M
    Book Value Per Share$5.61
    Total Assets$78.61M
    Total Liabilities$8.92M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$21.73M
    FCF Per Share-$5.50
    Depreciation and Amortization$5.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -29.82%.

    Gross Margin100.06%
    Operating Margin-29.82%
    Pretax Margin-20.86%
    Net Margin-20.86%

    Stock Splits

    The last split was a 1-for-40 reverse split on Nov 21, 2023.

    Last Split DateNov 21, 2023
    Split TypeReverse split
    Split Ratio1:40

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About VTVT

    What is VTVT's market cap?

    vTv Therapeutics has a market cap of $78.99M. Its enterprise value, which adds debt and subtracts cash, is $1.83M.

    How many shares of VTVT are outstanding?

    vTv Therapeutics has 12.42M shares outstanding. The count is up 54.22% from a year earlier.

    Does VTVT pay a dividend?

    No. vTv Therapeutics does not pay a dividend.

    How much debt does VTVT have?

    vTv Therapeutics has $0 of total debt and $77.16M of cash and equivalents, a net cash position of $77.16M.